Terms: = Thyroid cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Staging
81 results:
1. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ata initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
2. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
[TBL] [Abstract] [Full Text] [Related]
3. Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification.
Ding W; Gao X; Ran X
Front Endocrinol (Lausanne); 2023; 14():1273472. PubMed ID: 38303977
[TBL] [Abstract] [Full Text] [Related]
4. The American thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology.
Croce L; Teliti M; Chytiris S; Sparano C; Coperchini F; Villani L; Calì B; Petrone L; Magri F; Trimboli P; Rotondi M
Eur J Endocrinol; 2024 Feb; 190(2):165-172. PubMed ID: 38298148
[TBL] [Abstract] [Full Text] [Related]
5. How do
Mukhtar N; Alhamoudi K; Alswailem M; Alhindi H; Murugan AK; Alghamdi B; Alzahrani AS
Front Endocrinol (Lausanne); 2023; 14():1270796. PubMed ID: 37859987
[TBL] [Abstract] [Full Text] [Related]
6. Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ata risk categories and TNM.
Sapuppo G; Grasso S; Di Benedetto G; Belfiore A; Pellegriti G
Front Endocrinol (Lausanne); 2023; 14():1128963. PubMed ID: 36992807
[TBL] [Abstract] [Full Text] [Related]
7. Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
Patti L; Gay S; Musso L; Maltese C; Spina B; Minuto M; Morbelli S; Vera L; Boschetti M; Ferone D; Albertelli M
J Endocrinol Invest; 2023 Oct; 46(10):2157-2164. PubMed ID: 36976482
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of staging and recurrence predictors in patients with differentiated thyroid cancer between the 7th and 8th editions of the American Joint Committee on cancer staging systems.
Elbasan O; Gogas Yavuz D
Minerva Endocrinol (Torino); 2023 Sep; 48(3):261-273. PubMed ID: 36756784
[TBL] [Abstract] [Full Text] [Related]
9. Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study.
Pérez-Fernández L; Sastre J; Zafón C; Oleaga A; Castelblanco E; Capel I; Galofré JC; Guadalix-Iglesias S; De la Vieja A; Riesco-Eizaguirre G
Front Endocrinol (Lausanne); 2022; 13():1071775. PubMed ID: 36714606
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and histopathological features of follicular thyroid cancer in Chile.
Díaz R; Domínguez JM; Tala H; Olmos R; Pineda P; Olivarí D; Jiménez M; Mimica X; Lanas A; Ocares G; Sapunar J
Arch Endocrinol Metab; 2023 Mar; 67(3):348-354. PubMed ID: 36651709
[TBL] [Abstract] [Full Text] [Related]
11. Mutation-based, short-term "neoadjuvant" treatment allows resectability in stage IVB and C anaplastic thyroid cancer.
Maurer E; Eilsberger F; Wächter S; Riera Knorrenschild J; Pehl A; Holzer K; Neubauer A; Luster M; Bartsch DK
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1509-1518. PubMed ID: 36637521
[TBL] [Abstract] [Full Text] [Related]
12. Surgeon-performed ultrasound changes surgical management in patients with thyroid cancer.
Tapia M; Chia C; Manji J; Magarey MJR; Flatman S
ANZ J Surg; 2022 Dec; 92(12):3268-3272. PubMed ID: 36151922
[TBL] [Abstract] [Full Text] [Related]
13. Radioiodine therapy in the different stages of differentiated thyroid cancer.
Valerio L; Maino F; Castagna MG; Pacini F
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101703. PubMed ID: 36151009
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Utility of Tumor Stage versus American thyroid Association Risk Class in thyroid cancer.
Abiri A; Pang J; Prasad KR; Goshtasbi K; Kuan EC; Armstrong WB; Haidar YM; Tjoa T
Laryngoscope; 2023 Jan; 133(1):205-211. PubMed ID: 35716358
[TBL] [Abstract] [Full Text] [Related]
15. Concepts of Pathological staging and Prognosis in Papillary thyroid Carcinoma.
Lam AK
Methods Mol Biol; 2022; 2534():109-119. PubMed ID: 35670971
[TBL] [Abstract] [Full Text] [Related]
16. A Retrospective Cohort Study with Validation of Predictors of Differentiated thyroid cancer Outcomes.
Wijewardene A; Gill AJ; Gild M; Learoyd DL; Glover AR; Sywak M; Sidhu S; Roach P; Schembri G; Hoang J; Robinson B; Tacon L; Clifton-Bligh R
Thyroid; 2022 Oct; 32(10):1201-1210. PubMed ID: 35620896
[No Abstract] [Full Text] [Related]
17. Risk stratification in patients with anaplastic thyroid carcinoma: role of age.
Wang M; Wei T; Gong R; Zhu J; Li Z
Endocrine; 2022 Aug; 77(2):305-318. PubMed ID: 35608773
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
Zhang C; Li B; Zhang L; Chen F; Zhang Y; Cheng W
BMC Cancer; 2022 Apr; 22(1):354. PubMed ID: 35365120
[TBL] [Abstract] [Full Text] [Related]
19. A novel prognostic model based on log odds of positive lymph nodes to predict outcomes of patients with anaplastic thyroid carcinoma after surgery.
Tang J; Tian Y; Xi X; Ma J; Li H; Wang L; Zhang B
Clin Endocrinol (Oxf); 2022 Dec; 97(6):822-832. PubMed ID: 35355304
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in thyroid cancer.
Al Hatmi A; Jain A; Mittal AK; Hussain S
Sultan Qaboos Univ Med J; 2022 Feb; 22(1):74-81. PubMed ID: 35299812
[TBL] [Abstract] [Full Text] [Related]
[Next]